6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically NETWORK CONTRACT OFFICE 4 (36C244), has awarded a contract for Specialty Pharmaceutical Lenalidomide to EXELAN PHARMACEUTICALS INC. The award, valued at $1,487,248.49, covers the supply of various strengths of Lenalidomide oral capsules to the Erie facility.
Scope of Work
The contract requires the supply of Lenalidomide in the following oral capsule strengths:
- 10MG CAP, ORAL
- 5MG CAP, ORAL
- 15MG CAP, ORAL
- 25MG CAP, ORAL
Contract & Timeline
- Type: Award Notice (resulting from solicitation 36C24426Q0217)
- Award Number: 36F79720D0227 36C24426N0400
- Award Value: $1,487,248.49
- Awarded To: EXELAN PHARMACEUTICALS INC
- Award Date: February 6, 2026
- Contract Period: February 6, 2026, to February 5, 2027 (Base Period)
- Product Service Code: 6505 (Drugs and Biologicals)
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- Set-Aside: Not specified.
Evaluation
The original solicitation (36C24426Q0217) was for a Lowest Price Technically Acceptable (LPTA) award, as indicated in the opportunity title.
Additional Notes
This notice confirms the award for the supply of essential pharmaceutical products to support VA operations.